Tag results:
Publication
Human Immunology News
Chemokine- and Chemokine Receptor-Based Signature Predicts Immunotherapy Response in Female Colorectal Adenocarcinoma Patients
[Scientific Reports] The authors explored the expression profiles of chemokines and chemokine receptors and constructed a chemokine- and chemokine receptor-based signature in female patients with advanced colorectal adenocarcinoma.
Neural Cell News
Bortezomib Is Toxic but Induces Neurogenesis and Inhibits TUBB3 Degradation in Rat Neural Stem Cells
[Biomolecules & Therapeutics] Investigators explored the effects of bortezomib (BTZ) on rat neural stem cells. BTZ induced cell death, but the percentage of neurons was increased in the presence of mitogens.
Neural Cell News
Transplantation of Neural Stem Cells-Overexpressed Ku70 Improves Neurological Deficits in a Mice Model of Cerebral Ischemia Stroke
[Neurochemical Research] NSCs were induced by oxygen-glucose deprivation/reoxygenation for constructing cerebral ischemic stroke cell model.
Immune Regulation News
Screening for Lipid Nanoparticles That Modulate the Immune Activity of Helper T Cells towards Enhanced Antitumor Activity
[Nature Biomedical Engineering] The authors reported an lipid nanoparticle-screening method for the optimization of the type of helper lipid and of lipid-component ratios to enhance the delivery of tumor-antigen-encoding mRNA to dendritic cells and their immune-activation profile towards enhanced antitumor activity.
Immune Regulation News
BLK Positively Regulates TLR/IL-1R Signaling by Catalyzing TOLLIP Phosphorylation
[Journal of Cell Biology] Scientists showed that B lymphoid tyrosine kinase (BLK) positively regulated TLR/IL-1R–mediated inflammatory response. BLK-deficient mice produced less inflammatory cytokines and were more resistant to death upon IL-1β challenge.
Immune Regulation News
Immune Modulation of Innate and Adaptive Responses Restores Immune Surveillance and Establishes Anti-Tumor Immunological Memory
[Cancer Immunology Research] Using a mouse model of ovarian cancer, researchers demonstrated the oncolytic effect and immune-modulatory capacities of CARG-2020.